Viemed Healthcare Inc (VMD.CA) Fundamental Analysis & Valuation

TSX:VMD • CA92663R1055

10.45 CAD
+0.29 (+2.85%)
Last: Dec 21, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VMD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to VMD. VMD was compared to 13 industry peers in the Health Care Providers & Services industry. VMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VMD suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. VMD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year VMD was profitable.
  • VMD had a positive operating cash flow in the past year.
VMD.CA Yearly Net Income VS EBIT VS OCF VS FCFVMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

1.2 Ratios

  • The Return On Assets of VMD (6.16%) is better than 95.24% of its industry peers.
  • VMD has a Return On Equity of 8.47%. This is in the better half of the industry: VMD outperforms 76.19% of its industry peers.
  • The Return On Invested Capital of VMD (7.90%) is better than 90.48% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for VMD is above the industry average of 7.67%.
Industry RankSector Rank
ROA 6.16%
ROE 8.47%
ROIC 7.9%
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
VMD.CA Yearly ROA, ROE, ROICVMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 10 20 30

1.3 Margins

  • VMD's Profit Margin of 5.42% is amongst the best of the industry. VMD outperforms 90.48% of its industry peers.
  • VMD's Profit Margin has declined in the last couple of years.
  • The Operating Margin of VMD (7.73%) is better than 90.48% of its industry peers.
  • VMD's Operating Margin has declined in the last couple of years.
  • VMD has a better Gross Margin (61.00%) than 90.48% of its industry peers.
  • In the last couple of years the Gross Margin of VMD has declined.
Industry RankSector Rank
OM 7.73%
PM (TTM) 5.42%
GM 61%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
VMD.CA Yearly Profit, Operating, Gross MarginsVMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VMD.CA Health Analysis

2.1 Basic Checks

  • VMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • VMD has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for VMD has been reduced compared to a year ago.
VMD.CA Yearly Shares OutstandingVMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
VMD.CA Yearly Total Debt VS Total AssetsVMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 6.66 indicates that VMD is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of VMD (6.66) is better than 90.48% of its industry peers.
  • VMD has a debt to FCF ratio of 0.65. This is a very positive value and a sign of high solvency as it would only need 0.65 years to pay back of all of its debts.
  • VMD has a better Debt to FCF ratio (0.65) than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that VMD is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.08, VMD belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.65
Altman-Z 6.66
ROIC/WACC0.94
WACC8.43%
VMD.CA Yearly LT Debt VS Equity VS FCFVMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that VMD should not have too much problems paying its short term obligations.
  • The Current ratio of VMD (1.14) is comparable to the rest of the industry.
  • VMD has a Quick Ratio of 1.14. This is a bad value and indicates that VMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VMD has a Quick ratio (0.99) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.99
VMD.CA Yearly Current Assets VS Current LiabilitesVMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. VMD.CA Growth Analysis

3.1 Past

  • VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.05%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -6.17% on average over the past years.
  • The Revenue has grown by 27.38% in the past year. This is a very strong growth!
  • VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.23% yearly.
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 54.71% on average over the next years. This is a very strong growth
  • VMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.44% yearly.
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VMD.CA Yearly Revenue VS EstimatesVMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
VMD.CA Yearly EPS VS EstimatesVMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. VMD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 34.83 indicates a quite expensive valuation of VMD.
  • VMD's Price/Earnings ratio is rather cheap when compared to the industry. VMD is cheaper than 80.95% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (26.29), we can say VMD is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 19.28, which indicates a rather expensive current valuation of VMD.
  • VMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. VMD is cheaper than 85.71% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (24.57), we can say VMD is valued slightly cheaper.
Industry RankSector Rank
PE 34.83
Fwd PE 19.28
VMD.CA Price Earnings VS Forward Price EarningsVMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • VMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. VMD is cheaper than 76.19% of the companies in the same industry.
  • VMD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 19.11
EV/EBITDA 9.09
VMD.CA Per share dataVMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VMD has a very decent profitability rating, which may justify a higher PE ratio.
  • VMD's earnings are expected to grow with 54.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y65.14%
EPS Next 3Y54.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VMD.CA Dividend Analysis

5.1 Amount

  • VMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

VMD.CA Fundamentals: All Metrics, Ratios and Statistics

Viemed Healthcare Inc

TSX:VMD (12/21/2023, 7:00:00 PM)

10.45

+0.29 (+2.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners31.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap402.32M
Revenue(TTM)169.78M
Net Income(TTM)9.21M
Analysts80
Price Target19.25 (84.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-18.46%
Max EPS beat(2)18.81%
EPS beat(4)2
Avg EPS beat(4)8.43%
Min EPS beat(4)-18.46%
Max EPS beat(4)48.51%
EPS beat(8)3
Avg EPS beat(8)-0.69%
EPS beat(12)5
Avg EPS beat(12)22.7%
EPS beat(16)7
Avg EPS beat(16)24.4%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-1.19%
Max Revenue beat(2)3.2%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)3.2%
Revenue beat(8)6
Avg Revenue beat(8)1.73%
Revenue beat(12)8
Avg Revenue beat(12)1.84%
Revenue beat(16)10
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)-5.45%
EPS NY rev (3m)-5.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)96920.2%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 34.83
Fwd PE 19.28
P/S 1.79
P/FCF 19.11
P/OCF 7.66
P/B 2.79
P/tB 3.87
EV/EBITDA 9.09
EPS(TTM)0.3
EY2.87%
EPS(NY)0.54
Fwd EY5.19%
FCF(TTM)0.55
FCFY5.23%
OCF(TTM)1.36
OCFY13.05%
SpS5.84
BVpS3.74
TBVpS2.7
PEG (NY)0.46
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.16%
ROE 8.47%
ROCE 11.15%
ROIC 7.9%
ROICexc 8.64%
ROICexgc 12.03%
OM 7.73%
PM (TTM) 5.42%
GM 61%
FCFM 9.36%
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
ROICexc(3y)16.33%
ROICexc(5y)18.87%
ROICexgc(3y)16.33%
ROICexgc(5y)18.87%
ROCE(3y)16.03%
ROCE(5y)18.81%
ROICexgc growth 3Y-20.42%
ROICexgc growth 5Y-25.33%
ROICexc growth 3Y-20.42%
ROICexc growth 5Y-25.33%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.65
Debt/EBITDA 0.25
Cap/Depr 116.84%
Cap/Sales 13.98%
Interest Coverage 24.31
Cash Conversion 118.48%
Profit Quality 172.53%
Current Ratio 1.14
Quick Ratio 0.99
Altman-Z 6.66
F-Score4
WACC8.43%
ROIC/WACC0.94
Cap/Depr(3y)152.39%
Cap/Depr(5y)165.61%
Cap/Sales(3y)14.43%
Cap/Sales(5y)13.89%
Profit Quality(3y)59.5%
Profit Quality(5y)83.35%
High Growth Momentum
Growth
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
EBIT growth 1Y35.22%
EBIT growth 3Y-1.87%
EBIT growth 5Y-0.68%
EBIT Next Year275.8%
EBIT Next 3Y76.08%
EBIT Next 5YN/A
FCF growth 1Y829.24%
FCF growth 3Y-5.24%
FCF growth 5Y-9.57%
OCF growth 1Y101.83%
OCF growth 3Y13.28%
OCF growth 5Y18.21%

Viemed Healthcare Inc / VMD.CA FAQ

What is the ChartMill fundamental rating of Viemed Healthcare Inc (VMD.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to VMD.CA.


Can you provide the valuation status for Viemed Healthcare Inc?

ChartMill assigns a valuation rating of 5 / 10 to Viemed Healthcare Inc (VMD.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for Viemed Healthcare Inc?

Viemed Healthcare Inc (VMD.CA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of Viemed Healthcare Inc (VMD.CA) stock?

The Price/Earnings (PE) ratio for Viemed Healthcare Inc (VMD.CA) is 34.83 and the Price/Book (PB) ratio is 2.79.


What is the earnings growth outlook for Viemed Healthcare Inc?

The Earnings per Share (EPS) of Viemed Healthcare Inc (VMD.CA) is expected to grow by 75.07% in the next year.